Global Large Volume Wearable Injectors Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Large Volume Wearable Injectors Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.

According to APO Research, The global Large Volume Wearable Injectors market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Large Volume Wearable Injectors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Large Volume Wearable Injectors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Large Volume Wearable Injectors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Large Volume Wearable Injectors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Large Volume Wearable Injectors include West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical AG, BD Medical, Enable Injections, Roche Laboratories, scPharmaceuticals and SteadyMed Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Large Volume Wearable Injectors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Large Volume Wearable Injectors, also provides the sales of main regions and countries. Of the upcoming market potential for Large Volume Wearable Injectors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Large Volume Wearable Injectors sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Large Volume Wearable Injectors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Large Volume Wearable Injectors sales, projected growth trends, production technology, application and end-user industry.

Large Volume Wearable Injectors segment by Company

West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Large Volume Wearable Injectors segment by Type

Electronical Injectors
Mechanical Injectors
Others
Large Volume Wearable Injectors segment by Application

Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Large Volume Wearable Injectors segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Large Volume Wearable Injectors status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Large Volume Wearable Injectors market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Large Volume Wearable Injectors significant trends, drivers, influence factors in global and regions.
6. To analyze Large Volume Wearable Injectors competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Wearable Injectors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Large Volume Wearable Injectors and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Wearable Injectors.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Large Volume Wearable Injectors market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Large Volume Wearable Injectors industry.
Chapter 3: Detailed analysis of Large Volume Wearable Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Large Volume Wearable Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Large Volume Wearable Injectors in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Large Volume Wearable Injectors Sales Value (2019-2030)
1.2.2 Global Large Volume Wearable Injectors Sales Volume (2019-2030)
1.2.3 Global Large Volume Wearable Injectors Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Large Volume Wearable Injectors Market Dynamics
2.1 Large Volume Wearable Injectors Industry Trends
2.2 Large Volume Wearable Injectors Industry Drivers
2.3 Large Volume Wearable Injectors Industry Opportunities and Challenges
2.4 Large Volume Wearable Injectors Industry Restraints
3 Large Volume Wearable Injectors Market by Company
3.1 Global Large Volume Wearable Injectors Company Revenue Ranking in 2023
3.2 Global Large Volume Wearable Injectors Revenue by Company (2019-2024)
3.3 Global Large Volume Wearable Injectors Sales Volume by Company (2019-2024)
3.4 Global Large Volume Wearable Injectors Average Price by Company (2019-2024)
3.5 Global Large Volume Wearable Injectors Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Large Volume Wearable Injectors Company Manufacturing Base & Headquarters
3.7 Global Large Volume Wearable Injectors Company, Product Type & Application
3.8 Global Large Volume Wearable Injectors Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Large Volume Wearable Injectors Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Large Volume Wearable Injectors Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Large Volume Wearable Injectors Market by Type
4.1 Large Volume Wearable Injectors Type Introduction
4.1.1 Electronical Injectors
4.1.2 Mechanical Injectors
4.1.3 Others
4.2 Global Large Volume Wearable Injectors Sales Volume by Type
4.2.1 Global Large Volume Wearable Injectors Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Large Volume Wearable Injectors Sales Volume by Type (2019-2030)
4.2.3 Global Large Volume Wearable Injectors Sales Volume Share by Type (2019-2030)
4.3 Global Large Volume Wearable Injectors Sales Value by Type
4.3.1 Global Large Volume Wearable Injectors Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Large Volume Wearable Injectors Sales Value by Type (2019-2030)
4.3.3 Global Large Volume Wearable Injectors Sales Value Share by Type (2019-2030)
5 Large Volume Wearable Injectors Market by Application
5.1 Large Volume Wearable Injectors Application Introduction
5.1.1 Cancer Treatment
5.1.2 Auto-immune Treatment
5.1.3 Blood Disorders Treatment
5.1.4 Others
5.2 Global Large Volume Wearable Injectors Sales Volume by Application
5.2.1 Global Large Volume Wearable Injectors Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Large Volume Wearable Injectors Sales Volume by Application (2019-2030)
5.2.3 Global Large Volume Wearable Injectors Sales Volume Share by Application (2019-2030)
5.3 Global Large Volume Wearable Injectors Sales Value by Application
5.3.1 Global Large Volume Wearable Injectors Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Large Volume Wearable Injectors Sales Value by Application (2019-2030)
5.3.3 Global Large Volume Wearable Injectors Sales Value Share by Application (2019-2030)
6 Large Volume Wearable Injectors Market by Region
6.1 Global Large Volume Wearable Injectors Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Large Volume Wearable Injectors Sales by Region (2019-2030)
6.2.1 Global Large Volume Wearable Injectors Sales by Region: 2019-2024
6.2.2 Global Large Volume Wearable Injectors Sales by Region (2025-2030)
6.3 Global Large Volume Wearable Injectors Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Large Volume Wearable Injectors Sales Value by Region (2019-2030)
6.4.1 Global Large Volume Wearable Injectors Sales Value by Region: 2019-2024
6.4.2 Global Large Volume Wearable Injectors Sales Value by Region (2025-2030)
6.5 Global Large Volume Wearable Injectors Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Large Volume Wearable Injectors Sales Value (2019-2030)
6.6.2 North America Large Volume Wearable Injectors Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Large Volume Wearable Injectors Sales Value (2019-2030)
6.7.2 Europe Large Volume Wearable Injectors Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Large Volume Wearable Injectors Sales Value (2019-2030)
6.8.2 Asia-Pacific Large Volume Wearable Injectors Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Large Volume Wearable Injectors Sales Value (2019-2030)
6.9.2 Latin America Large Volume Wearable Injectors Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Large Volume Wearable Injectors Sales Value (2019-2030)
6.10.2 Middle East & Africa Large Volume Wearable Injectors Sales Value Share by Country, 2023 VS 2030
7 Large Volume Wearable Injectors Market by Country
7.1 Global Large Volume Wearable Injectors Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Large Volume Wearable Injectors Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Large Volume Wearable Injectors Sales by Country (2019-2030)
7.3.1 Global Large Volume Wearable Injectors Sales by Country (2019-2024)
7.3.2 Global Large Volume Wearable Injectors Sales by Country (2025-2030)
7.4 Global Large Volume Wearable Injectors Sales Value by Country (2019-2030)
7.4.1 Global Large Volume Wearable Injectors Sales Value by Country (2019-2024)
7.4.2 Global Large Volume Wearable Injectors Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.5.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.6.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.7.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.8.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.9.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.10.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.11.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.12.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.13.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.14.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.15.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.16.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.17.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.18.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.19.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.20.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.21.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.22.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Large Volume Wearable Injectors Sales Value Growth Rate (2019-2030)
7.23.2 Global Large Volume Wearable Injectors Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Large Volume Wearable Injectors Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 West Pharmaceuticals
8.1.1 West Pharmaceuticals Comapny Information
8.1.2 West Pharmaceuticals Business Overview
8.1.3 West Pharmaceuticals Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.1.4 West Pharmaceuticals Large Volume Wearable Injectors Product Portfolio
8.1.5 West Pharmaceuticals Recent Developments
8.2 Unilife Corporation
8.2.1 Unilife Corporation Comapny Information
8.2.2 Unilife Corporation Business Overview
8.2.3 Unilife Corporation Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.2.4 Unilife Corporation Large Volume Wearable Injectors Product Portfolio
8.2.5 Unilife Corporation Recent Developments
8.3 CeQur
8.3.1 CeQur Comapny Information
8.3.2 CeQur Business Overview
8.3.3 CeQur Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.3.4 CeQur Large Volume Wearable Injectors Product Portfolio
8.3.5 CeQur Recent Developments
8.4 Sensile Medical AG
8.4.1 Sensile Medical AG Comapny Information
8.4.2 Sensile Medical AG Business Overview
8.4.3 Sensile Medical AG Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.4.4 Sensile Medical AG Large Volume Wearable Injectors Product Portfolio
8.4.5 Sensile Medical AG Recent Developments
8.5 BD Medical
8.5.1 BD Medical Comapny Information
8.5.2 BD Medical Business Overview
8.5.3 BD Medical Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.5.4 BD Medical Large Volume Wearable Injectors Product Portfolio
8.5.5 BD Medical Recent Developments
8.6 Enable Injections
8.6.1 Enable Injections Comapny Information
8.6.2 Enable Injections Business Overview
8.6.3 Enable Injections Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.6.4 Enable Injections Large Volume Wearable Injectors Product Portfolio
8.6.5 Enable Injections Recent Developments
8.7 Roche Laboratories
8.7.1 Roche Laboratories Comapny Information
8.7.2 Roche Laboratories Business Overview
8.7.3 Roche Laboratories Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.7.4 Roche Laboratories Large Volume Wearable Injectors Product Portfolio
8.7.5 Roche Laboratories Recent Developments
8.8 scPharmaceuticals
8.8.1 scPharmaceuticals Comapny Information
8.8.2 scPharmaceuticals Business Overview
8.8.3 scPharmaceuticals Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.8.4 scPharmaceuticals Large Volume Wearable Injectors Product Portfolio
8.8.5 scPharmaceuticals Recent Developments
8.9 SteadyMed Therapeutics
8.9.1 SteadyMed Therapeutics Comapny Information
8.9.2 SteadyMed Therapeutics Business Overview
8.9.3 SteadyMed Therapeutics Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.9.4 SteadyMed Therapeutics Large Volume Wearable Injectors Product Portfolio
8.9.5 SteadyMed Therapeutics Recent Developments
8.10 Johnson & Johnson
8.10.1 Johnson & Johnson Comapny Information
8.10.2 Johnson & Johnson Business Overview
8.10.3 Johnson & Johnson Large Volume Wearable Injectors Sales, Value and Gross Margin (2019-2024)
8.10.4 Johnson & Johnson Large Volume Wearable Injectors Product Portfolio
8.10.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Large Volume Wearable Injectors Value Chain Analysis
9.1.1 Large Volume Wearable Injectors Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Large Volume Wearable Injectors Sales Mode & Process
9.2 Large Volume Wearable Injectors Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Large Volume Wearable Injectors Distributors
9.2.3 Large Volume Wearable Injectors Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings